Abstract
Nintedanib (NIN), a multi-tyrosine kinase inhibitor clinically approved for idiopathic pulmonary fibrosis and lung cancer, is characterized by protonation-dependent lysosomotropic behavior and appearance of lysosome-specific fluorescence emission properties. Here we investigate whether spontaneous formation of a so far unknown NIN matter within the acidic cell compartment is underlying these unexpected emissive properties and investigate the consequences on lysosome functionality. Lysosomes of cells treated with NIN, but not non-protonatable NIN derivatives, exhibited lysosome-associated birefringence signals co-localizing with the NIN-derived fluorescence emission. Sensitivity of both parameters towards vATPase inhibitors confirmed pH-dependent, spontaneous adoption of novel crystalline NIN structures in lysosomes. Accordingly, NIN crystallization from buffer solutions resulted in formation of multiple crystal polymorphs with pH-dependent fluorescence properties. Cell-free crystals grown at lysosomal-like pH conditions resembled NIN-treated cell lysosomes concerning fluorescence pattern, photobleaching dynamics, and Raman spectra. However, differences in birefringence intensity and FAIM-determined anisotropy, as well as predominant association with (intra)lysosomal membrane structures, suggested formation of a semi-solid NIN crystalline matter in acidic lysosomes. Despite comparable target kinase inhibition, NIN, but not its non-protonatable derivatives, impaired lysosomal functionality, mediated massive cell vacuolization, enhanced autophagy, deregulated lipid metabolism, and induced atypical phospholipidosis. Moreover, NIN exerted distinct phototoxicity, strictly dependent on lysosomal microcrystallization events. The spontaneous formation of NIN crystalline structures was also observable in the gut mucosa of orally NIN-treated mice. Summarizing, the here-described kinase inhibition-independent impact of NIN on lysosomal functionality mediates several of its cell biological activities and might contribute to NIN adverse effects.
| Original language | English |
|---|---|
| Article number | 111243 |
| Journal | Chemico-Biological Interactions |
| Volume | 403 |
| DOIs | |
| Publication status | Published - 1 Nov 2024 |
Funding
This work was supported by Austrian Science Fund (FWF) within the MUW International PhD program in Translational Oncology (IPPTO; project number DOC59-B33) and the Obermann-Mahlke Stiftung.We are grateful to Prof. Dr. Jan Lagerwall and Dr. Yong Geng for their collaboration with the POM experimental studies (Department of Physics and Material Science, University of Luxembourg, Luxembourg), as well as Prof. Dr. Daniel Abankwa and Dr. Elisabeth Schaffner-Reckinger for their technical support (Department of Life Sciences and Medicine, Campus Belval, University of Luxembourg, Luxembourg). We thank Mirjana Stojanovic, Petra Vician, Daniel Valcanover for skillful technical assistance and Johannes Reisecker for supporting FACS analyses (Center of Cancer Research, Comprehensive Cancer Center, Vienna, Austria). This work was supported by Austrian Science Fund (FWF) within the MUW International PhD program in Translational Oncology (IPPTO; project number DOC59-B33).
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Austrian Fields of Science 2012
- 301306 Medical molecular biology
- 106002 Biochemistry
- 301206 Pharmacology
Keywords
- Crystallization
- Fluorescence
- Lysosomotropism
- Nintedanib
- Phospholipidosis
- Phototoxicity
Fingerprint
Dive into the research topics of 'The tyrosine kinase inhibitor Nintedanib induces lysosomal dysfunctionality: Role of protonation-dependent crystallization processes'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver